Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Advanced Materials Regulatory News (MGAM)

Share Price Information for Morgan Advanced Materials (MGAM)

Share Price is delayed by 15 minutes
Get Live Data
228.50    0.50 (0.22%)
Bid:
228.00
Ask:
229.00
Spread: 1.00 (0.439%)
Market Cap: £631.61m
MGAM Live PriceLast checked at - London Stock Exchange

Intraday Morgan Advanced Materials Share Chart

Interim Management Statement

17 Nov 2010 07:00

RNS Number : 3048W
Morgan Crucible Co PLC
17 November 2010
 



Press Release

Interim Management Statement

The Morgan Crucible Company plc

17th November 2010

 

 

The statement below constitutes Morgan Crucible's Interim Management Statement for the period from 4th July to 17th November 2010.

 

 

·; The Group has continued to see positive trading momentum over the period since it reported its half year results

 

·; Profits for the full year are now expected to be in the top half of analyst forecasts*

 

·; In the ten month period to October year-on-year revenue growth was c.7%. Excluding NP Aerospace and at constant currency, revenue growth over the same period was c.16%, compared to the c.10% reported at the half year

 

·; Good progress is being made to realise the benefits of the divisional streamlining that was announced at the interim results. Our expectation remains to deliver at least £5m of cost savings in 2011 rising to £6-8m in 2012

 

·; The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end, driven by good cash generation from the positive trading performance

 

 

* Analyst forecasts for 2010 EBITA (before restructuring) are between £98.8m and £109.0m.

 

 

 

Outlook

 

With the Group continuing to see good trading momentum across most of its end markets, our outlook remains positive. In addition our ongoing focus on higher margin niche end markets, coupled with continuing benefits from cost base reductions, leaves us well placed for further progress into 2011.

 

  

Morgan Ceramics Division

 

The Technical Ceramics and Thermal Ceramics businesses were merged in July 2010 and are now run under a single integrated leadership team which is making good progress to realise both cost synergies and revenue growth opportunities.

 

Technical Ceramics Business

 

The majority of markets that Technical Ceramics serve have been showing improved demand during the year. US markets, in particular, have recovered strongly, Asian demand is growing well and Europe, though more subdued, is also showing a positive trend. Across the Technical Ceramics business, strong order intake through the year has resulted in order books building steadily from the trough levels of 2009.

 

Aerospace markets have recovered well from the slowdown seen in mid 2009 with our US metals business, in particular, benefitting from its alignment with this sector.

Demand for consumer electronics has been robust and the take-up of our new products in hard disk drive applications is very encouraging. The medical device market remains soft for the time being, mainly due to destocking in the supply chain, but there are some signs of recovery potential for 2011. In power generation, the continued weakness of the industrial gas turbine market held back our Certech businesses, in both the US and Europe, whilst solar, which started the year slowly, picked up in the second half.

 

 

Thermal Ceramics Business

 

Thermal Ceramics continued to see improving end market demand across all regions in the third quarter of the year. As a result, order books in emerging markets, particularly China and India, have continued to improve and the North America and Europe regions have also seen an increase in activity.

 

The chemical and petroleum sector remains robust with good demand in the Middle East and Latin America. Iron and steel demand has recovered from a very low base, as well as revenues from the automotive industry.

 

 

Morgan Engineered Materials Division

 

Advanced Materials &Technology Business - (formerly Carbon)

 

The Advanced Materials & Technology business has continued to recover across the broad range of its end markets in the third quarter of the year. Of particular note has been the strength of growth in our China business. The cost reduction initiatives started in 2009 and continuing in 2010, combined with our commitment to a low cost strategy, continue to yield benefits in our operating profit levels. We continue to pursue opportunities in the renewable energy sector with growing success in both the wind and solar energy markets.

 

 

NP Aerospace

 

NP Aerospace is expected to deliver 2010 revenues in line with our previously stated expectations of c.£120m. The business continues to pursue a number of domestic and international opportunities with existing and new customers. To support this, we have officially launched NP Aerospace in the US, opening an office in Detroit, and we are actively engaged with potential new customers on current and future US programmes.

 

 

 Molten Metal Systems

 

The strong performance in the Molten Metal Systems business in the first half has continued through the third quarter and we have continued to see increased demand levels in emerging markets.

 

 

Financial position

 

There was no material change in the financial position of the Group during the period. The Group's net debt to EBITDA ratio is expected to be comfortably below 2 times at the year end.

 

 

For further enquiries:

Mark Robertshaw

Morgan Crucible

01753 837000

Kevin Dangerfield

Rollo Head/Clare Hunt

Finsbury

020 7251 3801

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBIBDBIXBBGGL
Date   Source Headline
26th Nov 20247:00 amRNSTransaction in Own Shares
25th Nov 20247:00 amRNSTransaction in Own Shares
22nd Nov 20247:00 amRNSTransaction in Own Shares
21st Nov 20247:00 amRNSTransaction in Own Shares
20th Nov 202412:01 pmRNSDirector/PDMR Shareholding
20th Nov 20247:00 amRNSTransaction in Own Shares
19th Nov 202410:58 amRNSHolding(s) in Company
19th Nov 20247:00 amRNSTransaction in Own Shares
18th Nov 20247:00 amRNSTransaction in Own Shares
15th Nov 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Update
5th Nov 20247:00 amRNSCommencement of Share Buyback Programme
1st Oct 202412:03 pmRNSHolding(s) in Company
23rd Aug 202412:59 pmRNSHolding(s) in Company
20th Aug 20248:58 amRNSHolding(s) in Company
6th Aug 20247:00 amRNSHalf-year results
24th Jul 20247:00 amRNSDirectorate Change
17th Jun 202410:01 amRNSBlock listing Interim Review
13th Jun 20249:32 amRNSDirector/PDMR Shareholding
12th Jun 202412:05 pmRNSDirector/PDMR Shareholding
3rd Jun 20243:52 pmRNSDirector/PDMR Shareholding
22nd May 20245:17 pmRNSDirector/PDMR Shareholding
10th May 20245:21 pmRNSDirector/PDMR Shareholding
9th May 20241:59 pmRNSResult of AGM
9th May 20247:00 amRNSQ1 Trading Update
1st May 20245:38 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSCapital Markets Update
5th Apr 202412:55 pmRNSAnnual Financial Report
4th Apr 20241:16 pmRNSDirector/PDMR Shareholding
27th Mar 20244:52 pmRNSDirector/PDMR Shareholding
27th Mar 20244:50 pmRNSDirector/PDMR Shareholding
27th Mar 20244:49 pmRNSDirector/PDMR Shareholding
27th Mar 20244:48 pmRNSDirector/PDMR Shareholding
14th Mar 20249:42 amRNSDirector/PDMR Shareholding
14th Mar 20249:41 amRNSDirector/PDMR Shareholding
13th Mar 202412:10 pmRNSDirector/PDMR Shareholding
12th Mar 20247:00 amRNSMorgan Advanced Materials Full Year 2023 Results
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
19th Dec 20231:56 pmRNSDirector/PDMR Shareholding
18th Dec 20234:25 pmRNSBlock listing Interim Review
22nd Nov 202310:07 amRNSDirector/PDMR Shareholding
9th Nov 20237:00 amRNSQ3 Trading Update
9th Oct 20234:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.